Impact assessment

Hormone replacement therapy prescription prepayment certificate: equality impact assessment

The equality assessment presents the impacts of the introduction of the hormone replacement therapy prescription prepayment certificate (HRT PPC).

• From: Department of Health and Social Care
• Published: 31 March 2023

This was published under the 2022 to 2024 Sunak Conservative government

Applies to England

Documents

Introducing the HRT PPC: equality impact assessment

HTML

Details

The HRT PPC, available from 1 April 2023, will reduce the cost of HRT for people who pay for their prescriptions.

Patients prescribed HRT can save money and access their medicines by paying a one-off charge equivalent to 2 single prescription charges (£19.30) for all their HRT prescriptions for 12 months.

This equality assessment sets out the impacts that the HRT PPC will have on people based on shared characteristics such as sex, race and age.

Published 31 March 2023